Navigation Links
Life Sciences Discovery Fund makes company grants in health-related technologies
Date:7/24/2012

SEATTLE, Washington, July 23, 2012 The Life Sciences Discovery Fund (LSDF) today announced nearly $570,000 in awards in its inaugural corporate grant program to support commercialization of new health and health-care products by four early-stage Washington-based companies.

Three of the new "PreCede" grants focus on improving the management of serious medical conditions. Glenn Kawasaki of Carepeutics, Inc., will test a technology for predicting patient responses to anticancer drugs to inform treatment decisions. Tom Sanko of EchoGuide Medical, Inc. (formerly Harpoon Navigation, Inc.), will develop and test an ultrasound-guided system for placing catheters in the brain to drain excess cerebrospinal fluid. Robert Wilcox of Viket Medical Corporation will test a new approach for removing blood clots from the brains of individuals who have suffered a type of stroke called intracranial hemorrhage.

The fourth grant, to Thomas Schulte of Nexgenia, Inc., will optimize and scale up novel reagents to improve the speed and sensitivity of clinical assays for diagnosing various diseases.

The PreCede grant competition is designed to help position early-stage Washington life sciences companies for near-term equity investment. PreCede grants support research and development activities focused on validating the commercial merit of promising health-related technologies.

"LSDF has provided grant funding since 2007 to accelerate the movement of promising technologies into the commercial marketplace," stated LSDF Executive Director John DesRosier. "Today's grants represent LSDF's first dedicated mechanism to provide funding directly to companies. We have been encouraged and heartened by the strong support of and interest in this grant program from Washington's life sciences sector."

Washington Biotechnology & Biomedical Association President Chris Rivera noted that PreCede grants meet a vital need within the state's life sciences communi
'/>"/>

Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
2. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
3. New Anthropology and Archaeology Resources Published at Sciences Social Network
4. Novel Natural Sciences Repository Opens Web Portal
5. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
6. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
7. Ivy Neurological Sciences Internship program funded at TGen
8. Hutchinson Center president elected to American Academy of Art and Sciences
9. Washingtons Life Sciences Discovery Fund awards commercialization grants
10. Evolutionary information improves discovery of mutations associated with diseases
11. Discovery improves understanding of early onset inflammatory disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...
(Date:5/25/2013)... 2013 Ayurveda is the traditional ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... It believes that in order to re-establish optimal health, we ... then adopt a life style which brings us back into ...
(Date:5/25/2013)... 2013 The current residents of Back2Basics - ... the B2B staff all came together Saturday, May 18th to ... of Indian Cuisine, the residents got up to thank Roy ... on their road to recovery, and giving them a second ... center in 2010 after realizing the need for a long-term ...
(Date:5/25/2013)... 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , ... judge's overturning of a jury's award of $6.5 million ... trial* in the country over allegations that the diabetes ... files. , The judge in the case ruled that ... his cancer was caused by the medication.** , Bloomberg ...
(Date:5/25/2013)... 2013 AdvantaClean of Pikes Peak recently ... for a healthy home and business in Colorado Springs ... , mold inspections, mold testing, mold removal , ... coil cleaning. , With over 120 offices nationwide, AdvantaClean ... offering a full suite of services for commercial, institutional, ...
Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4
... diabetes found in mice could open the door to exploring ... System research has found. Drugs for type 2 diabetes ... U-M study suggests that glucagon a pancreas-produced hormone that ... levels may also provide a powerful pathway to preventing ...
... editors of Gastroenterology , the official journal of ... announce the publication of this year,s highly anticipated special ... devoted to a particular gastroenterological topic of broad interest; ... conjunction with editor-in-chief M. Bishr Omary, MD, PhD, this ...
... Maureen Salamon HealthDay Reporter , MONDAY, May 14 ... often played for drama or laughs, but the phenomenon is ... In what they said is the first research in ... from Stanford University School of Medicine found that about 3.6 ...
... A new national initiative promises to improve college biology ... change how post-secondary life sciences departments approach education. ... Education, is a collaborative effort funded by the National ... the Howard Hughes Medical Institute (HHMI). Program organizers ...
... ,Communities of Solution, to Address Today,s Fragmented U.S. Health ... to reform the U.S. health care system, a group ... of community-centered health systems, as originally outlined in the ... the original Folsom commission could not be more pertinent ...
... MONDAY, May 14 (HealthDay News) -- People with HIV/AIDS are ... than those in the general population, a new study finds. ... HIV, according to researchers from the University of California, San ... sudden cardiac death, the heart suddenly and unexpectedly stops beating. ...
Cached Medicine News:Health News:New inflammation hormone link may pave way to study new drugs for Type 2 diabetes 2Health News:Gastroenterology special issue focuses on new directions of viral hepatitis care and research 2Health News:Gastroenterology special issue focuses on new directions of viral hepatitis care and research 3Health News:Sleepwalking in Adults More Common Than Thought 2Health News:Sleepwalking in Adults More Common Than Thought 3Health News:National initiative launched to change the way biology departments approach undergraduate education 2Health News:National initiative launched to change the way biology departments approach undergraduate education 3Health News:May/June 2012 Annals of Family Medicine tip sheet 2Health News:May/June 2012 Annals of Family Medicine tip sheet 3Health News:May/June 2012 Annals of Family Medicine tip sheet 4Health News:May/June 2012 Annals of Family Medicine tip sheet 5Health News:May/June 2012 Annals of Family Medicine tip sheet 6Health News:May/June 2012 Annals of Family Medicine tip sheet 7Health News:May/June 2012 Annals of Family Medicine tip sheet 8Health News:People With HIV at Higher Odds of Sudden Cardiac Death 2
(Date:5/24/2013)... Solta Medical, Inc. (NASDAQ: SLTM ), ... Dr. Edward W. Knowlton has resigned ... immediately.  Dr. Knowlton is the founder of Thermage, the predecessor ... since 1996. "On behalf of the entire Board ... like to thank Ed for his tireless dedication to our ...
(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer").  On 20 ...
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: